M. Braun, S. Schlecht, M. Engelmann, W. Frank, S. Grimme
SHORT COMMUNICATION
2
2 2
and ∆F synthesis, minimization of Σw(Fo – Fc ) , 353 refined pa-
lute configuration at stereogenic boron could be assigned by
the evident accordance of measured and calculated circular
dichroism.
2
rameters, (∆/σ)max = 0.000, R1[Fo Ͼ 2σ(Fo2)] = 0.037, wR2
=
0.079 (all data), w = 1/[σ2(Fo2) + (0.02P)2 + 0.7P] where P =
2
2
(Fo + 2Fc )/3, S = 1.013, ∆ρmax/∆ρmin = +0.256 e/Å3 and
–0.129 e/Å3.
10a: Yellow solid, 268 mg (55%); Rf = 0.58 (chloroform/ethyl ace-
tate, 10:1); m.p. 179 °C. 1H NMR (500 MHz, CDCl3): δ = 4.6, 4.92
(d, J = 9.7 Hz, 2ϫ 1 H), 6.8 (m, 4 H), 7.2–7.34 (m, 10 H), 7.28
(d, Jo = 9.1 Hz, 1 H), 7.31 (m, 1 H), 7.42 (d, Jo = 8.0 Hz, 1 H),
7.58 (d, Jo = 8.0 Hz, 1 H), 7.72 (d, Jo = 8.0 Hz, 1 H), 7.95 (d, Jo
= 9.1 Hz, 1 H), 8.32 (s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 77.1, 77.4, 112.7, 120.5, 121.3, 124.6, 126.8, 127.7, 127.8, 128.3–
129.0, 129.0, 129.4, 131.8, 132.8, 138.5, 139.6, 140.5, 155.5, 162.5
ppm. 11B NMR (160 MHz, CDCl3): δ = 7.3 ppm.
Experimental Section
2
General Procedure for the Preparation of Boron Complexes 7 and
10: The corresponding imine, 5 or 9, (1.0 mmol), boronic acid 6
(1.5 mmol) and 1 g of molecular sieves (3 Å) were suspended in
100 mL of dry toluene and refluxed for 20 h. After filtration, the
solvent was removed in a rotary evaporatior and the residue was
purified by column chromatography (Fluka; silica gel 60, chloro-
form/ethyl acetate, 10:1) to deliver boronates 7a, 7b, and 10a–c as
yellow, solid compounds. For the preparation of boronate 7c, the
imine 5b was treated with (iPrO)2B(nBu) in an analogous way, how-
ever, in the absence of molecular sieves.
10b: Yellow solid, 209 mg (42%); Rf = 0.53 (chloroform/ethyl ace-
tate, 10:1); m.p. 240 °C. 1H NMR (500 MHz, CDCl3): δ = 4.6, 4.97
(d, 2J = 9.8 Hz, 2ϫ 1 H), 7.0–7.35 (m, 10 H), 7.29 (d, Jo = 9.1 Hz,
Selected Physical, Spectroscopic and Crystallographic Data
1 H), 7.32 (m, 2 H), 7.35 (m, 1 H), 7.46 (m, 1 H), 7.62 (d, Jo
=
8.1 Hz, 1 H), 7.65 (m, 2 H), 7.75 (d, Jo = 8.1 Hz, 1 H), 7.99 (d, Jo
= 9.1 Hz, 1 H), 8.39 (s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 77.1, 77.7, 112.5, 120.5, 121.0, 121.5, 124.9, 127.8, 127.8, 128.5–
129.0, 129.2, 129.5, 131.7, 138.1, 139.6, 140.0, 147.1, 155.6, 162.3
ppm. 11B NMR (160 MHz, CDCl3): δ = 6.9 ppm.
7a: Yellow solid, 238 mg (38%); Rf = 0.3 (chloroform/n-hexane,
1:1). H NMR (200 MHz, CDCl3): δ = 1.30 (s, 9 H), 1.37 (s, 9 H),
6.25 (s, 1 H), 6.27–6.31 (m, 2 H), 6.78–6.86 (m, 2 H), 6.92–6.98 (m,
2 H), 7.05–7.23 (m, 11 H), 7.36–7.40 (m, 3 H), 7.58 (s, 1 H), 7.65
(d, Jm = 2.5 Hz, 1 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 29.9,
31.7, 34.7, 35.9, 83.0, 87.4, 119.5–141.6, 159.2, 161.6 ppm.
1
Crystallographic data: C31H23BN2O4, Mr = 498.32, orthorhombic,
space group Iba2, a = 12.5991(9) Å, b = 18.5482(10) Å, c =
21.6143(12) Å, V = 5051.1(5) Å3, Z = 8, Dx = 1.311 g cm–3,
Crystallographic data: C41H41BClNO2, Mr = 626.01, monoclinic,
space group P21, a = 18.3345(9) Å, b = 10.8254(6) Å, c =
µ
=
0.087 mm–1,
T
=
291 K, crystal dimensions:
18.9903(10) Å, β = 110.593(6) °, V = 3528.3(3) Å3, Z = 4, Dx
=
0.4 mmϫ0.2 mmϫ0.2 mm, STOE-IPDS, Mo-Kα radiation (λ =
0.71073 Å), θmax = 25.00°,11612 measured, 2276 unique, and 1430
observed reflections with IϾ2σ(I), LP correction, direct methods
1.178 g cm–3, µ = 0.144 mm–1, T = 291 K, crystal dimensions:
0.3 mmϫ0.2 mmϫ0.15 mm, STOE-IPDS, Mo-Kα radiation (λ =
0.71073 Å), θmax = 26.07°, 39602 measured, 13815 unique, and
4471 observed reflections with IϾ2σ(I), LP correction, direct
2
2 2
and ∆F synthesis, minimization of Σw(Fo – Fc ) , 343 refined pa-
rameters, (∆/σ)max = 0.000, R1[Fo2 Ͼ 2σ(Fo2)] = 0.029, wR2 = 0.053
2
2 2
methods and ∆F synthesis, minimization of Σw(Fo – Fc ) , 841
(all data), w = 1/[σ2(Fo2) + (0.018P)2] where P = (Fo + 2Fc )/3, S
= 0.965, ∆ρmax/∆ρmin = +0.095 e/Å3 and –0.099 e/Å3.
2
2
2
refined parameters, (∆/σ)max = 0.001, R1[Fo Ͼ 2σ(Fo2)] = 0.042,
wR2 = 0.085 (all data), w = 1/σ2(Fo2), S = 0.828, ∆ρmax/∆ρmin
+0.166 e/Å3 and –0.141 e/Å3.
=
10c: Yellow solid, 294 mg (63%); Rf = 0.48 (chloroform/ethyl ace-
1
tate, 10:1); m.p. 192 °C. H NMR (500 MHz, CDCl3): δ = 2.06 (s,
7b: Yellow solid, 304 mg (54%); Rf = 0.61 (chloroform/ethyl ace-
3 H), 4.65, 4.89 (d, 2J = 9.5 Hz, 2ϫ 1 H), 6.7 (d, Jo = 7.8 Hz, 2
1
tate, 10:1); m.p. 214 °C. H NMR (500 MHz, CDCl3): δ = 6.2 (s, 1
H), 6.8 (d, Jo = 7.8 Hz, 2 H), 7.2–7.35 (m, 10 H), 7.27 (d, Jo
=
H), 6.87 (t, Jo = 7.7 Hz, 2 H), 6.9 (d, Jo = 8.1 Hz, 2 H), 7.1 (d, Jo
= 8.0 Hz, 2 H), 7.1–7.3 (m, 13 H), 7.3 (d, Jo = 9.0 Hz, 1 H), 7.32
(t, Jo = 7.6 Hz, 1 H), 7.39 (t, Jo = 7.6 Hz, 1 H), 7.5 (d, Jo = 8.1 Hz,
1 H), 7.74 (d, Jo = 8.0 Hz, 1 H), 7.98 (d, Jo = 9.1 Hz, 1 H), 8.0 (s,
1 H) ppm. 13C NMR (125 MHz, CDCl3): δ = 82.8, 87.2, 113.5,
120.6, 121.4, 124.7, 126.7, 126.8–129.0, 127.7, 127.8, 129.1, 129.4,
131.8, 133.1, 135.2, 138.7, 139.0, 139.6, 156.2, 163.6 ppm. 11B
NMR (160 MHz, CDCl3): δ = 6.82 ppm.
9.1 Hz, 1 H), 7.27 (t, Jo = 8.0 Hz, 1 H), 7.39 (t, Jo = 8.0 Hz, 1 H),
7.56 (d, Jo = 8.2 Hz, 1 H), 7.68 (d, Jo = 8.0 Hz, 1 H), 7.91 (d, Jo
= 9.1 Hz, 1 H), 8.29 (s, 1 H) ppm. 13C NMR (125 MHz, CDCl3):
δ = 21.1, 77.1, 77.2, 112.9, 120.5, 121.5, 124.4, 127.5, 127.7, 127.7–
128.7, 128.8, 129.3, 131.9, 132.3, 136.3, 138.9, 139.2, 141.5, 147.1,
155.6, 162.6 ppm. 11B NMR (160 MHz, CDCl3): δ = 4.6 ppm.
CCDC-689995 (for 7a), -689999 (for 7c), -689997 (for 10a·n-
C6H12), -689996 (for 10b), and -689998 (for 10c·0.5Et2O) contain
the supplementary crystallographic data. These data can be
obtained free of charge from The Director, CCDC, 12 Union
Road, Cambridge CB2 1EZ, UK (Fax: +44-1223-336033; E-mail:
7c: Yellow solid, 469 mg (92%); Rf = 0.69 (chloroform/ethyl ace-
1
tate, 10:1); m.p. 197 °C. H NMR (500 MHz, CDCl3): δ = 0.7 (t,
3J = 7.1 Hz, 3 H), 1.2 (m, 6 H), 6.1 (s, 1 H), 7.0–7.3 (m, 15 H), 7.2
(d, Jo = 9.1 Hz, 1 H), 7.28 (t, Jo = 7.1 Hz, 1 H), 7.38 (t, Jo
=
7.7 Hz, 1 H), 7.5 (d, Jo = 8.2 Hz, 1 H), 7.7 (d, Jo = 7.9 Hz, 1 H),
7.86 (s, 1 H), 7.9 (d, Jo = 9.0 Hz, 1 H) ppm. 13C NMR (125 MHz,
CDCl3): δ = 14.2, 26,1, 27.4, 82.2, 88.1, 113.9, 120.6, 121.8, 124.2,
127–130, 127.5, 128.6, 129.2, 132, 136.1, 138.5, 139.1, 139.3, 155,
163.4 ppm. 11B NMR (160 MHz, CDCl3): δ = 8.8 ppm.
Acknowledgments
This work was supported by the Deutsche Forschungsgemeinschaft
(DFG). We are grateful to Sabine Houben for her assistance with
the preparation of several compounds.
Crystallographic data: C35H32BNO2, Mr = 509.43, orthorhombic,
space group P212121,
c = 18.275(4) Å, V = 2882.8(10) Å3, Z = 4, Dx = 1.174 g cm–3,
0.071 mm–1,
293 K, crystal dimensions:
a = 11.019(2) Å, b = 14.315(3) Å,
µ
=
T
=
[1] For reviews, see: M. R. Barbachyn, C. R. Johnson, in Asym-
metric Synthesis, vol. 4 (Eds.: J. D. Morrison, J. W. Scott), Aca-
demic Press, San Diego, 1984, chapter 2; D. Valentine Jr., in
Asymmetric Synthesis, vol. 4 (Eds.: J. D. Morrison, J. W. Scott),
0.5 mmϫ0.1 mmϫ0.05 mm, STOE-IPDS, Mo-Kα radiation (λ =
0.71073 Å), θmax = 25.00°, 37818 measured, 2860 unique, and 1970
observed reflections with IϾ2σ(I), LP correction, direct methods
5224
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 5221–5225